Literature DB >> 11158037

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging.

S M Harman1, E J Metter, J D Tobin, J Pearson, M R Blackman.   

Abstract

Many studies have shown cross-sectional (and two small studies, longitudinal) declines in total and/or free testosterone (T) levels, with age, in men. The extent to which decline in T is the result of the aging process per se, as opposed to chronic illness, medication use, and other age-related factors, remains controversial. The frequency with which aging leads to T levels consistent with hypogonadism has also not been defined. These issues bear on the potential use of T replacement in aging men, because aging and hypogonadism have, in common, reduced bone and lean body mass and muscle strength and increased total and abdominal fat. We measured T and sex hormone-binding globulin (SHBG), by RIA, in stored samples from 890 men in the Baltimore Longitudinal Study on Aging. Using a mixed-effects model, we found independent effects of age and date of sampling to reduce T levels. After compensating for date effects, which investigation suggested was artifactual, we observed significant, independent, age-invariant, longitudinal effects of age on both T and free T index (free T index = T/SHBG), with an average change of -0.124 nmol/L.yr and -0.0049 nmol T/nmol SHBG.yr. T, but not free T index, also decreased with increasing body mass index. Use of beta-blocking drugs was associated with higher T and higher free T index levels. Using total T criteria, incidence of hypogonadal T levels increased to about 20% of men over 60, 30% over 70 and 50% over 80 yr of age, and even greater percentages when free T index criteria were employed. Our observations of health factor independent, age-related longitudinal decreases in T and free T, resulting in a high frequency of hypogonadal values, suggest that further investigation of T replacement in aged men, perhaps targeted to those with the lowest serum T concentrations, are justified.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158037     DOI: 10.1210/jcem.86.2.7219

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  627 in total

Review 1.  Hormone treatment and muscle anabolism during aging: androgens.

Authors:  E Lichar Dillon; William J Durham; Randall J Urban; Melinda Sheffield-Moore
Journal:  Clin Nutr       Date:  2010-05-07       Impact factor: 7.324

2.  Effect of 1 week of sleep restriction on testosterone levels in young healthy men.

Authors:  Rachel Leproult; Eve Van Cauter
Journal:  JAMA       Date:  2011-06-01       Impact factor: 56.272

3.  Effects of apigenin on steroidogenesis and steroidogenic acute regulatory gene expression in mouse Leydig cells.

Authors:  Wei Li; Akhilesh K Pandey; Xiangling Yin; Jau-Jiin Chen; Douglas M Stocco; Paula Grammas; Xingjia Wang
Journal:  J Nutr Biochem       Date:  2011-03       Impact factor: 6.048

4.  Fat-free mass index: changes and race/ethnic differences in adulthood.

Authors:  H R Hull; J Thornton; J Wang; R N Pierson; Z Kaleem; X Pi-Sunyer; S Heymsfield; J Albu; J R Fernandez; T B Vanitallie; D Gallagher
Journal:  Int J Obes (Lond)       Date:  2010-06-08       Impact factor: 5.095

Review 5.  [Intermittent androgen deprivation as therapy for androgen-sensitive prostate cancer. Sense or nonsense?].

Authors:  P Thelen; R-H Ringert; H Loertzer; A Strauß
Journal:  Urologe A       Date:  2012-09       Impact factor: 0.639

6.  Dose-dependent effects of androgens on the circadian timing system and its response to light.

Authors:  Matthew P Butler; Ilia N Karatsoreos; Joseph LeSauter; Rae Silver
Journal:  Endocrinology       Date:  2012-04-04       Impact factor: 4.736

Review 7.  Cognitive changes associated with ADT: a review of the literature.

Authors:  Rhoda J Jamadar; Mary J Winters; Pauline M Maki
Journal:  Asian J Androl       Date:  2012-02-20       Impact factor: 3.285

8.  Prostate magnetic resonance imaging findings in patients treated for testosterone deficiency while on active surveillance for low-risk prostate cancer.

Authors:  Takeshi Hashimoto; Krishnan Rahul; Toshikazu Takeda; Nicole Benfante; John P Mulhall; Hedvig Hricak; James A Eastham; Hebert Alberto Vargas
Journal:  Urol Oncol       Date:  2016-09-22       Impact factor: 3.498

Review 9.  [Hypogonadism in the elderly man. Reliable diagnosis and therapy].

Authors:  M Zitzmann; E Nieschlag
Journal:  Internist (Berl)       Date:  2003-10       Impact factor: 0.743

10.  Preliminary evidence that androgen signaling is correlated with men's everyday language.

Authors:  Jennifer S Mascaro; Kelly E Rentscher; Patrick D Hackett; Adriana Lori; Alana Darcher; James K Rilling; Matthias R Mehl
Journal:  Am J Hum Biol       Date:  2018-05-11       Impact factor: 1.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.